BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 31432170)

  • 1. Upregulated microRNA‑671‑3p promotes tumor progression by suppressing forkhead box P2 expression in non‑small‑cell lung cancer.
    Li ZY; Zhang ZZ; Bi H; Zhang QD; Zhang SJ; Zhou L; Zhu XQ; Zhou J
    Mol Med Rep; 2019 Oct; 20(4):3149-3159. PubMed ID: 31432170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR‑654‑3p suppresses cell viability and promotes apoptosis by targeting RASAL2 in non‑small‑cell lung cancer.
    Xiong J; Xing S; Dong Z; Niu L; Xu Q; Li Y; Liu P; Yang P
    Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33300072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
    Zhou Y; Li S; Li J; Wang D; Li Q
    Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR‑671‑3p is downregulated in non‑small cell lung cancer and inhibits cancer progression by directly targeting CCND2.
    Yao Y; Zhou Y; Fu X
    Mol Med Rep; 2019 Mar; 19(3):2407-2412. PubMed ID: 30664171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-625 inhibits the progression of non‑small cell lung cancer by directly targeting HOXB5 and deactivating the Wnt/β-catenin pathway.
    Tan X; Jiang L; Wu X; Feng W; Lin Q
    Int J Mol Med; 2019 Jul; 44(1):346-356. PubMed ID: 31115501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-29c inhibits proliferation and promotes apoptosis in non-small cell lung cancer cells by targeting VEGFA.
    Zhan S; Wang C; Yin F
    Mol Med Rep; 2018 May; 17(5):6705-6710. PubMed ID: 29512752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FOXP4 modulates tumor growth and independently associates with miR-138 in non-small cell lung cancer cells.
    Yang T; Li H; Thakur A; Chen T; Xue J; Li D; Chen M
    Tumour Biol; 2015 Sep; 36(10):8185-91. PubMed ID: 25994569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR‑139‑5p enhances cisplatin sensitivity in non‑small cell lung cancer cells by inhibiting cell proliferation and promoting apoptosis via the targeting of Homeobox protein Hox‑B2.
    Du H; Bao Y; Liu C; Zhong A; Niu Y; Tang X
    Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33300085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Significance and Tumor-Suppressive Function of miR-516b in Nonsmall Cell Lung Cancer.
    Zhu J; Zhang Y; Yang X; Jin L
    Cancer Biother Radiopharm; 2017 May; 32(4):115-123. PubMed ID: 28514208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NORAD regulates epithelial‑mesenchymal transition of non‑small cell lung cancer cells via miR‑422a.
    Chen Z; Che Q; Xie C
    Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33300080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long noncoding RNA CRNDE promotes non-small cell lung cancer progression via sponging microRNA-338-3p.
    Jing H; Xia H; Qian M; Lv X
    Biomed Pharmacother; 2019 Feb; 110():825-833. PubMed ID: 30554121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA‑28 promotes the proliferation of non‑small‑cell lung cancer cells by targeting PTEN.
    Cui F; Zhou Q; Xiao K; Qian H
    Mol Med Rep; 2020 Jun; 21(6):2589-2596. PubMed ID: 32236614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA‑92a promotes non‑small cell lung cancer cell growth by targeting tumor suppressor gene FBXW7.
    Ni D; Teng J; Cheng Y; Zhu Z; Zhuang B; Yang Z
    Mol Med Rep; 2020 Oct; 22(4):2817-2825. PubMed ID: 32945381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA FENDRR inhibits NSCLC cell growth and aggressiveness by sponging miR-761.
    Zhang MY; Zhang ZL; Cui HX; Wang RK; Fu L
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8324-8332. PubMed ID: 30556873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-183 promotes growth of non-small cell lung cancer cells through FoxO1 inhibition.
    Zhang L; Quan H; Wang S; Li X; Che X
    Tumour Biol; 2015 Sep; 36(10):8121-6. PubMed ID: 25983004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Propofol suppresses the progression of non‑small cell lung cancer via downregulation of the miR‑21‑5p/MAPK10 axis.
    Wu X; Li X; Xu G
    Oncol Rep; 2020 Aug; 44(2):487-498. PubMed ID: 32468043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-25 enhances cell migration and invasion in non-small-cell lung cancer cells via ERK signaling pathway by inhibiting KLF4.
    Ding X; Zhong T; Jiang L; Huang J; Xia Y; Hu R
    Mol Med Rep; 2018 May; 17(5):7005-7016. PubMed ID: 29568911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA‑433 reduces cell proliferation and invasion in non‑small cell lung cancer via directly targeting E2F transcription factor 3.
    Liu N; Liu Z; Zhang W; Li Y; Cao J; Yang H; Li X
    Mol Med Rep; 2018 Jul; 18(1):1155-1164. PubMed ID: 29767254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CircABCB10 promotes nonsmall cell lung cancer cell proliferation and migration by regulating the miR-1252/FOXR2 axis.
    Tian X; Zhang L; Jiao Y; Chen J; Shan Y; Yang W
    J Cell Biochem; 2019 Mar; 120(3):3765-3772. PubMed ID: 30417418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non‑coding RNA PITPNA‑AS1 silencing suppresses proliferation, metastasis and epithelial‑mesenchymal transition in non‑small cell lung cancer cells by targeting microRNA‑32‑5p.
    Chen G; Zheng Z; Li J; Zhang P; Wang Z; Guo S; Ma J; Shen J; Li H
    Mol Med Rep; 2021 Mar; 23(3):. PubMed ID: 33495838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.